30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Marc Stapley

Track

Insider profile

Currently holds a position at Glaukos Corp

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return 51% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Glaukos Corp July 1, 2014 -
Executive Vice President, Strategy and Corporate Development Illumina Inc Jan. 1, 2017 - Jan. 1, 2019
Executive Vice President, Chief Administrative Officer Illumina Inc Dec. 7, 2016 - Jan. 1, 2017
Chief Financial Officer, Executive Vice President, Chief Administrative Officer Illumina Inc Dec. 7, 2015 - Dec. 7, 2016
Chief Financial Officer, Senior Vice President Illumina Inc Jan. 20, 2012 - Dec. 7, 2015
Marc Stapley's trades of Veracyte Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-04 2026-06-04
US Veracyte Inc (VCYT)
PlS Planned sale
5,387 -31.0%
173.23
US$745,922 		5,387 -31.0% 173.23 US$745,922
2026-06-04 2026-06-04
US Veracyte Inc (VCYT)
PrS Proposed sale
21,921
27.12
US$2,092,229 		21,921 27.12 US$2,092,229
2026-03-06 2026-03-04
US Veracyte Inc (VCYT)
PlS Planned sale
42,363 +2.8%
370.14
US$3,969,286 		42,363 +2.8% 370.14 US$3,969,286
2026-03-06 2026-03-04
US Veracyte Inc (VCYT)
PlS Planned sale
19,244 -4.8%
35.56
US$684,226 		19,244 -4.8% 35.56 US$684,226
2026-03-04 2026-03-04
US Veracyte Inc (VCYT)
PrS Proposed sale
45,523
35.08
US$1,596,947 		45,523 35.08 US$1,596,947
2026-01-26 2026-01-22
US Glaukos Corp (GKOS)
PlS Planned sale
1,300 -3.4%
129.78
US$168,714 		1,300 -3.4% 129.78 US$168,714
2026-01-26 2026-01-22
US Glaukos Corp (GKOS)
PlS Planned sale
4,325 -10.0%
129.11
US$558,401 		4,325 -10.0% 129.11 US$558,401
2026-01-26 2026-01-22
US Glaukos Corp (GKOS)
PlS Planned sale
1,671 -3.7%
127.92
US$213,754 		1,671 -3.7% 127.92 US$213,754
2026-01-26 2026-01-22
US Glaukos Corp (GKOS)
PlS Planned sale
3,892 -8.0%
126.96
US$494,128 		3,892 -8.0% 126.96 US$494,128
2026-01-26 2026-01-22
US Glaukos Corp (GKOS)
PlS Planned sale
3,812 -7.3%
126.07
US$480,579 		3,812 -7.3% 126.07 US$480,579
2026-01-22 2026-01-22
US Glaukos Corp (GKOS)
PrS Proposed sale
15,000
127.70
US$1,915,560 		15,000 127.70 US$1,915,560
2025-12-04 2025-12-04
US Veracyte Inc (VCYT)
PrS Proposed sale
7,668
47.75
US$366,147 		7,668 47.75 US$366,147
2025-12-04 2025-12-04
US Veracyte Inc (VCYT)
PlS Planned sale
3,220 -1.0%
47.35
US$152,462 		3,220 -1.0% 47.35 US$152,462
2025-12-04 2025-12-04
US Veracyte Inc (VCYT)
PlS Planned sale
4,448 -1.4%
46.90
US$208,613 		4,448 -1.4% 46.90 US$208,613
2025-09-08 2025-09-04
US Veracyte Inc (VCYT)
PlS Planned sale
7,667 -2.2%
30.41
US$233,133 		7,667 -2.2% 30.41 US$233,133
2025-09-04 2025-09-04
US Veracyte Inc (VCYT)
PrS Proposed sale
7,667
30.62
US$234,764 		7,667 30.62 US$234,764
2025-03-06 2025-03-04
US Veracyte Inc (VCYT)
PlS Planned sale
1,094 -0.4%
34.37
US$37,599 		1,094 -0.4% 34.37 US$37,599
2025-03-06 2025-03-04
US Veracyte Inc (VCYT)
PlS Planned sale
23,414 -8.0%
33.91
US$794,009 		23,414 -8.0% 33.91 US$794,009
2025-03-06 2025-03-04
US Veracyte Inc (VCYT)
PlS Planned sale
28,189 -8.8%
32.82
US$925,248 		28,189 -8.8% 32.82 US$925,248
2025-03-04 2025-03-04
US Veracyte Inc (VCYT)
PrS Proposed sale
52,697
33.56
US$1,768,511 		52,697 33.56 US$1,768,511
2024-12-17 2024-12-13
US Veracyte Inc (VCYT)
PlS Planned sale
400 -0.1%
44.14
US$17,657 		400 -0.1% 44.14 US$17,657
2024-12-17 2024-12-13
US Veracyte Inc (VCYT)
PlS Planned sale
5,190 -1.7%
43.37
US$225,080 		5,190 -1.7% 43.37 US$225,080
2024-12-13 2024-12-13
US Veracyte Inc (VCYT)
PrS Proposed sale
5,590
44.40
US$248,196 		5,590 44.40 US$248,196
2024-08-19 2024-08-15
US Glaukos Corp (GKOS)
PlS Planned sale
581 -1.7%
126.91
US$73,735 		581 -1.7% 126.91 US$73,735
2024-08-19 2024-08-15
US Glaukos Corp (GKOS)
PlS Planned sale
3,959 -10.3%
126.27
US$499,903 		3,959 -10.3% 126.27 US$499,903
2024-08-19 2024-08-15
US Glaukos Corp (GKOS)
PlS Planned sale
1,110 -2.8%
125.28
US$139,061 		1,110 -2.8% 125.28 US$139,061
2024-08-19 2024-08-15
US Glaukos Corp (GKOS)
PlS Planned sale
600 -1.5%
123.98
US$74,388 		600 -1.5% 123.98 US$74,388
2024-08-15 2024-08-15
US Glaukos Corp (GKOS)
PrS Proposed sale
6,250
125.93
US$787,074 		6,250 125.93 US$787,074
2024-05-16 2024-05-15
US Glaukos Corp (GKOS)
PlS Planned sale
2,000 -5.8%
113.68
US$227,360 		2,000 -5.8% 113.68 US$227,360
2024-05-16 2024-05-15
US Glaukos Corp (GKOS)
PlS Planned sale
2,200 -6.0%
112.91
US$248,402 		2,200 -6.0% 112.91 US$248,402
2024-05-16 2024-05-15
US Glaukos Corp (GKOS)
PlS Planned sale
2,050 -5.3%
111.82
US$229,231 		2,050 -5.3% 111.82 US$229,231
2024-05-15 2024-05-15
US Glaukos Corp (GKOS)
PrS Proposed sale
6,250
112.28
US$701,750 		6,250 112.28 US$701,750
2024-03-04 2024-02-29
US Glaukos Corp (GKOS)
PlS Planned sale
2,313 -6.7%
91.21
US$210,969 		2,313 -6.7% 91.21 US$210,969
2024-03-04 2024-02-29
US Glaukos Corp (GKOS)
PlS Planned sale
1,500 -4.1%
90.54
US$135,810 		1,500 -4.1% 90.54 US$135,810
2024-03-04 2024-02-29
US Glaukos Corp (GKOS)
PlS Planned sale
2,437 -6.3%
88.76
US$216,308 		2,437 -6.3% 88.76 US$216,308
2024-02-29 2024-02-29
US Glaukos Corp (GKOS)
PrS Proposed sale
6,250
90.09
US$563,075 		6,250 90.09 US$563,075
2023-12-18 2023-12-14
US Glaukos Corp (GKOS)
PlS Planned sale
7,044 -18.4%
76.35
US$537,809 		7,044 -18.4% 76.35 US$537,809
2023-12-18 2023-12-14
US Glaukos Corp (GKOS)
PlS Planned sale
9,206 -19.4%
75.61
US$696,066 		9,206 -19.4% 75.61 US$696,066
2023-12-14 2023-12-14
US Glaukos Corp (GKOS)
PrS Proposed sale
16,250
75.93
US$1,233,818 		16,250 75.93 US$1,233,818
2022-06-13 2022-06-10
US Veracyte Inc (VCYT)
B Purchase
60,000 +60.1%
16.33
US$980,094 		60,000 +60.1% 16.33 US$980,094
2016-09-16 2016-09-15
US Illumina Inc (ILMN)
PlS Planned sale
100 -0.3%
170.08
US$17,008 		100 -0.3% 170.08 US$17,008